WEBULL
WebtradeDownload

T. Hasegawa (TSE:4958) Stock Trails Earnings Strength As Valuation Debate Deepens

Simply Wall St · 2d ago

T. Hasegawa stock has drifted over the past month and slipped slightly in the last week, yet the latest earnings tell a more supportive story for patient holders. Q3 basic earnings per share of ¥63.62 and net income of ¥2,582m sit on top of a trailing twelve month earnings profile that still prices the shares at a P/E of 16.7x. The real tension is that this fragrance and flavor specialist carries a richer multiple than chemicals peers while also screening well below a discounted cash flow fair value estimate.

Is T. Hasegawa trading at a misunderstood discount, or is the richer P/E simply too far ahead of fundamentals? Compare the current share price against our detailed valuation analysis for T. Hasegawa

Q3 2026 Earnings Summary

  • Revenue, Q3 2026 vs. Q3 2025: ¥21,770m vs. ¥18,725m (higher year on year)
  • Net Income, Q3 2026 vs. Q3 2025: ¥2,582m vs. ¥2,019m (higher year on year)
  • Basic EPS, Q3 2026 vs. Q3 2025: ¥63.62 vs. ¥49.41 (higher year on year)
  • Trailing 12 Month Revenue, Q3 2026 vs. Q3 2025: ¥78,302m vs. ¥73,488m (higher on a trailing basis)

Prefer clean, visual charts instead of scrolling through dense earnings tables and raw figures? View T. Hasegawa's full financial picture with an at-a-glance summary of its valuation setup in the interactive company report for T. Hasegawa.

TSE:4958 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
TSE:4958 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

T. Hasegawa results support steady-holder optimism

The latest Q3 numbers give bulls something concrete to point to. T. Hasegawa lifted revenue, net income and basic EPS compared with the same quarter last year, and the trailing 12 month revenue is also higher. That aligns with a view of a broadly resilient, consumer linked supplier that is still finding ways to grow its top line and earnings. For investors who see the business as a steady compounder tied to everyday products, this set of results broadly runs in the same direction as that thesis.

Short term share drift keeps risk questions alive

The share price has slipped slightly over 7 and 30 days, even with higher quarterly and trailing 12 month figures. That gap can feed the bearish view that the market is cautious about how durable this earnings run is. Bears may argue that a recent 90 day gain of about 13% already prices in some of the improvement, while the muted short term reaction hints at concern around future input costs, customer pricing pressure or broader cyclical risk in specialty ingredients.

With a richer P/E, slower forecast growth and a dividend commitment to fund, the key question is whether T. Hasegawa's balance sheet comfortably supports this profile. Verify the liquidity and debt picture in our financial health analysis of T. Hasegawa stock.

Stay Ahead With Simply Wall St

If the mix of a richer P/E and a discounted fair value estimate has you watching T. Hasegawa closely, register for free with Simply Wall St and add it to a Watchlist to track its share price against fair value and wait for an entry point that fits your plan. After you take a position, keep your focus with the Portfolio Command Center that cuts through noise and highlights only the key developments for your holdings. For longer term context and fresh angles on T. Hasegawa and similar stocks, tap into the insights shared in the Community. By spotting potential catalysts and risks early, you give yourself a better chance of staying ahead of the market rather than reacting to it.

Seeking Alternatives Beyond T. Hasegawa?

Fresh stock ideas move quickly. Some are building quiet breakout momentum under the radar for now and could be caught by the crowd later. Scan these curated lists and consider them while they are still early in their development.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.